Clinicians are curious about preclinical MRI and interested in the opportunities that preclinical models of neurodegenerative diseases grant in terms of manipulation and investigating therapeutic strategies. Here, we review the fundamental principles of preclinical neuroimaging that clinicians should be aware of prior to embarking on basic research experimentation.
No takes yet. Share an insight, caveat, or question.
Raman Saggu (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: